Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combined oral contraceptives: acceptability and effective use

A Kubba1, J Guillebaud

  • 1Department of Obstetrics and Gynaecology, United Medical and Dental Schools, St Thomas' Hospital, London, UK.

British Medical Bulletin
|January 1, 1993
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ominous-appearing papulonodules in the genitocrural area.

Clinical and experimental dermatology·2021
Same author

Severe epidermolysis bullosa/Kindler syndrome-like phenotype of an autoinflammatory syndrome in a child.

Clinical and experimental dermatology·2021
Same author

Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2017
Same author

Two novel mutations in KIND1 in Indian patients with Kindler syndrome.

Clinical and experimental dermatology·2016
Same author

Histopathological Diagnosis of Leprosy Type 1 Reaction with Emphasis on Interobserver Variation.

Indian journal of leprosy·2016
Same author

Intrauterine contraception - what now and what next?

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2014

Combined oral contraceptives (COCs) have improved safety and efficacy. Modern low-dose pills and selective progestogens reduce risks, but user education is key to improving compliance and addressing side effects.

Area of Science:

  • Reproductive Health
  • Pharmacology
  • Public Health

Background:

  • Combined oral contraceptives (COCs) are widely used globally, necessitating ongoing evaluation of their safety and efficacy.
  • Historical data from cohort and case-control studies have informed current practices in managing COC use.
  • Advancements in contraceptive technology focus on minimizing steroid dose and potency to reduce health risks.

Purpose of the Study:

  • To review the advancements in safety and efficacy of combined oral contraceptives.
  • To discuss the impact of modern low-dose formulations and new-generation progestogens.
  • To address the persistent issue of user failure and strategies for improvement.

Main Methods:

  • Review of existing literature on combined oral contraception safety and efficacy.
Keywords:
AmenorrheaBiologyCarbohydrate Metabolic EffectsContraceptionContraceptive EffectivenessContraceptive MethodsContraceptive Methods--contraindicationsContraceptive Methods--side effectsDiseasesFamily PlanningLipid Metabolic EffectsLipidsMenstruation DisordersMetabolic EffectsOral ContraceptivesOral Contraceptives, Combined--contraindicationsOral Contraceptives, Combined--side effectsOral Contraceptives, PhasicOral Contraceptives--contraindicationsOral Contraceptives--side effectsPhysiologyRisk FactorsVitamins

Related Experiment Videos

  • Analysis of the impact of steroid dose and potency on health risks and benefits.
  • Examination of the role of new progestogens (Desogestrel, Norgestimate, Gestodene) and their androgenicity.
  • Discussion of factors contributing to user failure, including compliance and perceived side effects.

    • Main Results:

    • Modern COCs, particularly low-dose preparations, have significantly reduced adverse effects while retaining non-contraceptive benefits.
    • Newer progestogens offer reduced androgenicity, improving the side effect profile.
    • Despite pharmaceutical advancements, high rates of user failure persist, primarily due to poor compliance and anxiety about side effects.

    Conclusions:

    • Continuous improvement in COC safety and efficacy has been achieved through dose reduction and development of selective progestogens.
    • Enhancing user compliance through better education and addressing concerns about side effects are crucial for maximizing contraceptive effectiveness.
    • Further research and education are needed to optimize the use of combined oral contraception worldwide.